Evidence map›Paper›PMID 24462303›Full record

ReviewTransplantation reviews (Orlando, Fla.)2014

Bone and mineral disorders after kidney transplantation: therapeutic strategies.

Miklos Z Molnar, Mohamed S Naser, Connie M Rhee, Kamyar Kalantar-Zadeh, Suphamai Bunnapradist

Open access · greenAbstract readReview
In one paragraph

Review in Transplantation reviews (Orlando, Fla.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Prevalence of Musculoskeletal and Metabolic Disorders in Kidney Transplant Recipients: A Systematic Review and Meta-Analysis.Transplant international : official journal of the European Society for Organ Transplantation · 2024
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 2 countries.

Miklos Z MolnarDivision of Nephrology and Hypertension, University of California Irvine Medical Center, Orange, CA, USA; Department of Medicine, Division of Nephrology, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Mohamed S NaserDepartment of Medicine, Division of Nephrology, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Connie M RheeDivision of Nephrology and Hypertension, University of California Irvine Medical Center, Orange, CA, USA.
Kamyar Kalantar-ZadehDivision of Nephrology and Hypertension, University of California Irvine Medical Center, Orange, CA, USA; Departments of Community Health Sciences and Epidemiology, UCLA Fielding School of Public Health, Los Angeles, CA, USA.
Suphamai BunnapradistDavid Geffen School of Medicine at UCLA, Los Angeles, CA, USA. Electronic address: bunnapradist@mednet.ucla.edu.
UCLA Health · USUniversity Health Network · CAUniversity of California, Irvine Medical Center · USUniversity of California, Los Angeles · USUniversity of Toronto · CA

Funding

TRAINING PROGRAM IN ACADEMIC NEPHROLOGYT32DK007527 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI BONVENTRE, JOSEPH VINCENT · 1986 to 2021
$8.8M
MALNUTRITION, DIET AND RACIAL DISPARITIES IN CKDK24DK091419 · NIDDK · UNIVERSITY OF CALIFORNIA-IRVINE · PI KALANTAR-ZADEH, KAMYAR · 2011 to 2020
$1.8M
Examining Racial and Cardiovascular Paradoxes in Chronic Kidney DiseaseR01DK078106 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KALANTAR-ZADEH, KAMYAR · 2007 to 2011
$1.1M
Comparative Effectiveness of Home Hemodialysis versus Kidney Transplantation in tR21AG047036 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI KALANTAR-ZADEH, KAMYAR, MOLNAR, MIKLOS ZSOLT · 2013 to 2014
$424k
NIA NIH HHS R21AG047036NIDDK NIH HHS K24 DK091419NIDDK NIH HHS R01 DK078106NIDDK NIH HHS T32 DK007527
6 · The paper itself

Abstract

Mineral and bone diseases (MBD) are common in patients with chronic kidney disease who undergo kidney transplantation. The incidence, types and severity of MBD vary according to the duration of chronic kidney disease, presence of comorbid conditions and intake of certain medications. Moreover, multiple types of pathology may be responsible for MBD. After successful reversal of uremia by kidney transplantation, many bone and mineral disorders improve, while immunosuppression, other medications, and new and existing comorbidities may result in new or worsening MBD. Chronic kidney disease is also common after kidney transplantation and may impact bone and mineral disease. In this article, we reviewed the prevalence, pathophysiology, and impact of MBD on post-transplant outcomes. We also discussed the diagnostic approach; immunosuppression management and potential treatment of MBD in kidney transplant recipients.

Indexed as

Absorptiometry, PhotonBone DensityBone Diseases, MetabolicCombined Modality TherapyFemaleHumansKidney TransplantationMalePrevalencePrognosisRenal Insufficiency, ChronicRisk AssessmentSeverity of Illness IndexTreatment Outcome

Identifiers

PMID24462303
PMCPMC5588857
OpenAlexW1980135014

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.